Date: 2014-01-10
Type of information: R&D agreement
Compound: chemistry research
Company: Selvita (Poland) Chiesi Farmaceutici (Italy)
Therapeutic area: Cardiovascular diseases - Respiratory diseases
Type agreement: R&D
Action mechanism:
Disease: respiratory, cardiovascular and special care disorders
Details: * On January 10, 2014, Selvita, Poland-based integrated drug discovery partner for the pharmaceutical and biotechnology industry, has extended its chemistry research collaboration with Chiesi Farmaceutici from Italy.
The collaboration between Chiesi and Selvita started with fee-for-service chemical synthesis in 2011. After the successful completion of several projects, it evolved into FTE-based collaboration in 2012-2013. The joint projects support Chiesi proprietary drug discovery and development pipeline, which is focused on respiratory, cardiovascular and special care disorders.
Financial terms:
Latest news:
